Edimer Pharmaceuticals

About:

Edimer Pharmaceuticals develops a treatment to improve the health and quality of life of families living with XLHED.

Website: http://edimerpharma.com

Twitter/X: EdimerPharma

Top Investors: New Enterprise Associates, Third Rock Ventures, VI Partners, Sanofi Ventures

Description:

Edimer Pharmaceuticals: Working toward improving the health and quality of life of families living with XLHED. Edimer Pharmaceuticals is dedicated to developing EDI200 as a treatment for X-linked Hypohydrotic Ectodermal Dysplasia (XLHED). XLHED is a rare, orphan disease that causes a range of symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. Edimer is led by a team of seasoned biotechnology industry veterans with deep experience in drug development complemented by a strong network of world-class clinical and scientific advisers.